HR 9358 · 117th Congress
Access to Innovative Treatments Act of 2022
This bill creates a formal process for reviewing Medicare's decisions to deny or limit coverage of newly approved drugs and biologicals (medical treatments). Right now, when Medicare decides not to cover a new medication that the FDA has already approved, there's no clear way for patients, doctors, or drug manufactu…
- Sponsor
- Barragan, Nanette Diaz (D-CA)
- Introduced
- 2022-11-29
- Policy area
- Health
- Latest action
- Referred to the Subcommittee on Health.
Digging through Congress... 🔍